2.45
price up icon0.82%   0.02
after-market アフターアワーズ: 2.36 -0.09 -3.67%
loading
前日終値:
$2.43
開ける:
$2.45
24時間の取引高:
726.73K
Relative Volume:
0.20
時価総額:
$682.59M
収益:
$12.87M
当期純損益:
$-114.34M
株価収益率:
-2.8337
EPS:
-0.8646
ネットキャッシュフロー:
$-79.23M
1週間 パフォーマンス:
+1.66%
1か月 パフォーマンス:
-11.87%
6か月 パフォーマンス:
+27.60%
1年 パフォーマンス:
+13.95%
1日の値動き範囲:
Value
$2.391
$2.49
1週間の範囲:
Value
$2.25
$2.505
52週間の値動き範囲:
Value
$1.05
$3.31

Taysha Gene Therapies Inc Stock (TSHA) Company Profile

Name
名前
Taysha Gene Therapies Inc
Name
セクター
Healthcare (1160)
Name
電話
(214) 612-0000
Name
住所
3000 PEGASUS PARK DRIVE, DALLAS
Name
職員
73
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
TSHA's Discussions on Twitter

TSHA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TSHA
Taysha Gene Therapies Inc
2.45 682.59M 12.87M -114.34M -79.23M -0.8646
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Taysha Gene Therapies Inc Stock (TSHA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-06-27 開始されました BMO Capital Markets Outperform
2024-04-09 開始されました Piper Sandler Overweight
2023-02-01 ダウングレード Jefferies Buy → Hold
2023-01-27 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-11-09 ダウングレード Goldman Buy → Neutral
2022-03-09 開始されました Robert W. Baird Outperform
2022-03-01 開始されました Wells Fargo Overweight
2022-02-18 開始されました SMBC Nikko Outperform
2021-12-16 開始されました Guggenheim Buy
2021-07-16 開始されました Needham Buy
2021-06-24 開始されました Truist Buy
2021-06-15 開始されました BTIG Research Buy
2021-06-09 開始されました Wedbush Outperform
2021-06-08 開始されました JMP Securities Mkt Outperform
2021-05-19 開始されました Cantor Fitzgerald Overweight
2021-05-11 再開されました Jefferies Buy
2021-02-24 開始されました William Blair Outperform
2021-01-05 開始されました Oppenheimer Outperform
2020-10-19 開始されました Chardan Capital Markets Buy
2020-10-19 開始されました Goldman Buy
2020-10-19 開始されました Jefferies Buy
2020-10-19 開始されました Morgan Stanley Overweight
すべてを表示

Taysha Gene Therapies Inc (TSHA) 最新ニュース

pulisher
Jun 14, 2025

Taysha Gene Therapies’ SWOT analysis: promising Rett syndrome therapy boosts stock outlook - Investing.com Australia

Jun 14, 2025
pulisher
Jun 13, 2025

Taysha Gene Therapies price target maintained at $13 by Cantor Fitzgerald - Investing.com Canada

Jun 13, 2025
pulisher
Jun 12, 2025

Taysha gene therapies stock rating reiterated by Cantor Fitzgerald - Investing.com Canada

Jun 12, 2025
pulisher
Jun 11, 2025

Taysha Gene Therapies (TSHA) Price Target Raised Amid High Trial Success Confidence | TSHA Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Adjusts Price Target on Taysha Gene Therapies to $13 From $7, Maintains Overweight Rating - MarketScreener

Jun 11, 2025
pulisher
Jun 10, 2025

Needham Reiterates Buy Rating for Taysha Gene Therapies (TSHA) | - GuruFocus

Jun 10, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Li - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Signify Bio’s $15M round advances in situ protein therapeutics - BioWorld MedTech

Jun 06, 2025
pulisher
Jun 06, 2025

Kalkine: Taysha Gene Therapies Grants Equity Awards to New Joiners – A Closer Look at FTSE 350 Companies' Global Peers - Kalkine Media

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | TSHA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies (TSHA) Grants Stock Options to New Employees | TSHA Stock News - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Taysha Gene Therapies Grants Stock Options to New Employees Under Inducement Plan - Nasdaq

Jun 06, 2025
pulisher
Jun 06, 2025

Gene Therapy Leader Taysha Awards Massive 401K Share Options Package to Key New Executives - Stock Titan

Jun 06, 2025
pulisher
Jun 05, 2025

Finance Watch: Vera Raises Debt, Taysha And Trevi Price Offering After Big Trial Wins - insights.citeline.com

Jun 05, 2025
pulisher
Jun 05, 2025

Taysha Gene Therapies Stock (TSHA): Innovative Gene Therapy Focus - Value The Markets

Jun 05, 2025
pulisher
Jun 04, 2025

Taysha Gene Therapies Releases TSHA-102 Clinical Program Updates - Insider Monkey

Jun 04, 2025
pulisher
Jun 04, 2025

Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Purchased by ProShare Advisors LLC - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

BNP Paribas Financial Markets Acquires New Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Jane Street Group LLC Acquires 62,003 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Taysha Gene Therapies (NASDAQ:TSHA) Given New $11.00 Price Target at Canaccord Genuity Group - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Taysha reports progress in Rett syndrome gene therapy trials By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

Retail Buzz Surges Around Taysha Gene Therapies After Positive Rett Syndrome Trial Data By Stocktwits - Investing.com India

Jun 03, 2025
pulisher
Jun 03, 2025

taysha gene therapies increases authorized shares to 700 million By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies (TSHA) Advances TSHA-102 Program for Rett - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details for Oral Presentations a - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha reports progress in Rett syndrome gene therapy trials - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program - The Manila Times

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details For Oral Presentations - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program | TSHA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Announces Details for Oral - GlobeNewswire

Jun 03, 2025
pulisher
Jun 03, 2025

Needham Lifts Taysha Gene Therapies (TSHA) PT to $8, Cites Positive Clinical Data - Insider Monkey

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies’ (TSHA) Buy Rating Reaffirmed at Needham & Company LLC - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies (TSHA) Target Price Raised by Canaccord Ge - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies (TSHA) Price Target Raised by Canaccord | - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

taysha gene therapies increases authorized shares to 700 million - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies Approves Share Increase Amendment - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Taysha Gene Therapies (TSHA) Price Target Raised by Canaccord | TSHA Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

Positive Outlook for Taysha Gene Therapies: Buy Rating on Promising TSHA-102 Advancements - TipRanks

Jun 02, 2025
pulisher
Jun 02, 2025

Taysha Gene Therapies (TSHA) Updates Clinical Progress in Rett S - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Where Taysha Gene Therapies Stands With Analysts - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Needham Adjusts Taysha Gene Therapies Price Target to $8 From $6, Maintains Buy Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Taysha Gene Therapies (TSHA) Sees Increased Price Target by Needham | TSHA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Needham Increases Price Target for Taysha Gene Therapies (TSHA) to $8 | TSHA Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Taysha Gene Therapies (TSHA) Price Target Raised by JMP on Positive Rett Syndrome Trial Data - MSN

Jun 02, 2025
pulisher
Jun 02, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 02, 2025
pulisher
Jun 02, 2025

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Stake Lessened by Deutsche Bank AG - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

Bank of America Corp DE Boosts Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World

Jun 01, 2025

Taysha Gene Therapies Inc (TSHA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
大文字化:     |  ボリューム (24 時間):